Phase I clinical trial with a novel protease inhibitor for HIV, KVX-478, in healthy male volunteers: Masahiko Nishiyama, Misa Koishi, Minoru Fujioka, Kazuma Hirata, Akitoshi Yamamoto, Hisao Suzuki, and Yoshikazu Kurashina (Kissei Pharmaceutical Co., Ltd., Matsumoto, Japan), Munetetsu Tei and Kazuo Uebaba (Bio-Iatric Center, Kitazato Laboratory, Tokyo, Japan)
- 30 April 1996
- journal article
- abstracts
- Published by Elsevier in Antiviral Research
- Vol. 30 (1) , A35
- https://doi.org/10.1016/0166-3542(96)80287-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: